0% found this document useful (0 votes)
288 views1 page

Clinical Manual of Geriatric Psychopharmacology. Sandra A. Jacobson (2014) Washington, DC: American Psychiatric Publishing. Second Edition. 536 PP

Cccc

Uploaded by

Cindy Gautama
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
0% found this document useful (0 votes)
288 views1 page

Clinical Manual of Geriatric Psychopharmacology. Sandra A. Jacobson (2014) Washington, DC: American Psychiatric Publishing. Second Edition. 536 PP

Cccc

Uploaded by

Cindy Gautama
Copyright
© © All Rights Reserved
We take content rights seriously. If you suspect this is your content, claim it here.
Available Formats
Download as PDF, TXT or read online on Scribd
You are on page 1/ 1

BOOK REVIEW

Clinical Manual of Geriatric interactions, protein binding, metabolism, as neurocognitive disorders due to neurodegen-
well as clearance in both the kidney and the erative disorders such as Alzheimer's and
Psychopharmacology. liver are described. Medical considerations Parkinson's disease. It addresses not only cog-
and instructions for drug prescribing practices nitive enhancing treatment but also the role
Sandra A. Jacobson (2014) are included and are particularly relevant for of these drugs in managing agitation and
Washington, DC: those medically compromised older patients other behavioral symptoms of these dementing
seen in clinical practices. A fairly compre- illnesses.
American Psychiatric hensive list of medications to be avoided in Throughout the text, there are highlighted
Publishing. Second select geriatric patient populations due to po- boxes that share brief, clinically relevant facts
tential complications is also presented. This that will aid the clinician in formulating their
Edition. 536 pp. table clearly delineates the rationale why they treatment plans. All chapters can be used as a
should be avoided, as well as the strength of quick reference for specific drugs use or clini-

T he population in the United States is aging


rapidly. Geriatric patients pose a challenge
to health care providers that is unique from
that recommendation.
Further chapters are broken down into the
major psychotropic medication groups: anti-
cally important questions. Alternatively, the
book could also be a practical read, which will
further educate any clinician on the topic of
their younger counterparts. The elderly are psychotics, antidepressants, mood stabilizers, geriatric psychopharmacology. The text fully
faced with a plethora of chronic medical ill- and anxiolytics/sedative hypnotics. Commonly conforms to the more recent Diagnostic and
nesses, neurodegenerative disorders, as well used agents are listed in each chapter along Statistical Manual of Mental Disorders, 5th
as psychiatric conditions and symptoms that with their available formulations and doses Edition, diagnostic criteria. The terminology,
complicate their management. In addition, ge- available on the market. It is not a comprehen- medications, and reference as written are clear
riatric psychiatric conditions, such as depres- sive list of all psychiatric medications available and up-to-date.
sion, chronic psychiatric illness, and cognitive today, but it does include those agents that are In summary, Sandra A. Jacobson's Clini-
disorders are commonly seen in primary care by far most commonly prescribed in the geriat- cal Manual of Geriatric Psychopharmacology,
practices. Most physicians and health care pro- ric population. Again, specific pharmacody- in its second edition, is a useful reference guide to
viders need to be well prepared to treat these namics and pharmacokinetic principles such any physician or health care provider treating
complex patients in later life. General and as metabolism, drug interactions, and clear- geriatric psychiatric disorders. It is also con-
geriatric psychiatrists in particular must be ance are listed. Diagnostic and symptom indi- cisely written, with plenty of clinically relevant
well versed in the pharmacological manage- cations as well as the recommended length of material, and it can be read on its own to ex-
ment of the psychiatrically impaired elderly. use for each drug are also listed. Common pand one's knowledge base. Only a minority
Sandra A. Jacobson's Clinical Manual of Ge- and less common side effects are discussed at of physicians and health care providers receive
riatric Psychopharmacology, in its second edi- length. Each drug listed has a brief summary specialty training in geriatrics. This book clearly
tion, serves as both an outstanding reference of dosage recommendations, doses available, can serve as one tool toward their essential
book as well as a complete yet concise prac- and other details as provided at the end of education in geriatric health care.
tical guide to the complex issues in geriatric each chapter.
psychopharmacology for providers who treat The manual continues by including sev-
geriatric patients. eral chapters that discuss the treatment of
In the first chapter, the manual gives a conditions commonly seen in geriatric indi-
Elizabeth A. Crocco, MD
Chief, Geriatric Psychiatry
broad yet extremely useful overview of the viduals that require psychopharmacologic in-
Associate Clinical Professor
general concepts and prescribing practices in tervention. Chapters that detail the treatment
Department of Psychiatry
psychopharmacology. Although discussions of of movement disorders, substance related-
and Behavioral Sciences
general patients are included, the author also disorders, as well as pain management have
Miller School of Medicine
specifies those geriatric guidelines and pre- particular value for the clinician treating pa-
University of Miami
scribing recommendations that clearly differ tients in late-life. Each chapter again gives an
Miami, FL
in this population. Both general pharmaco- easily digestible summary for each specific
kinetic and pharmacodynamic issues in psy- medication at the end of each chapter. Parti-
chopharmacology are covered from a primary cularly well-written is a comprehensive yet
clinical perspective with, again, an added practical chapter dedicated to those medica- DISCLOSURE
emphasis on geriatrics differences. Drug-drug tions currently available to treat the major The author declares no conflict of interest.

330 www.jonmd.com The Journal of Nervous and Mental Disease • Volume 204, Number 4, April 2016

Copyright © 2016 Wolters Kluwer Health, Inc. All rights reserved.

You might also like

pFad - Phonifier reborn

Pfad - The Proxy pFad of © 2024 Garber Painting. All rights reserved.

Note: This service is not intended for secure transactions such as banking, social media, email, or purchasing. Use at your own risk. We assume no liability whatsoever for broken pages.


Alternative Proxies:

Alternative Proxy

pFad Proxy

pFad v3 Proxy

pFad v4 Proxy